Supplements and Featured Publications
Managed Care Interventions for Improving Outcomes in Acute Heart Failure Syndromes
Volume 14
Issue 9 Suppl

Participating Faculty

Managed Care Interventions for Improving Outcomes in Acute Heart Failure Syndromes

This supplement to The American Journal of Managed Care provides information on the diagnosis and management of acute heart failure syndromes. Novel managed care interventions to improve the quality of care for acute heart failure syndromes and manage the financial burden of the disease are discussed.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

  • Faculty

Jeffrey D. Dunn, PharmD, MBA

Formulary and Contracts Manager

SelectHealth Plans

Salt Lake City, Utah

Gregg C. Fonarow, MD, FAHA, FACC

Professor of Cardiovascular Medicine

Associate Chief, Division of Cardiology

Geffen School of Medicine at UCLA

Los Angeles, California

Mihai Gheorghiade, MD, FACC

Professor of Medicine and Surgery

Associate Chief, Division of Cardiology

Northwestern University

Feinberg School of Medicine

Chicago, Illinois

Sadiya Sana Khan, BS

Division of Cardiology

Northwestern University

Feinberg School of Medicine

Chicago, Illinois

Ed Pezalla, MD, MPH

National Medical Director, Pharmacy Management

Aetna Pharmacy Management

Hartford, Connecticut

  • Faculty Disclosures

The faculty has reported the following:

Gregg C. Fonarow, MD, FAHA, FACC

Research grants: GlaxoSmithKline, Medtronic, National Institutes of Health, Novartis

Consultant and Honoraria: GlaxoSmithKline, Medtronic, Novartis, Pfizer, Scios

Mihai Gheorghiade, MD, FACC

Research grants: Merck, National Institutes of Health, Otsuka, Scios Inc, Sigma Tau

Consultant: Debbio Pharm, Errekappa Terapeutici, GlaxoSmithKline, Johnson & Johnson, Medtronic, Protein Design Labs, Solvay

Honoraria: Abbott, AstraZeneca, GlaxoSmithKline, Medtronic, Otsuka, Protein Design Labs, Scios Inc, Sigma Tau

Jeffrey D. Dunn, PharmD, MBA, Ed Pezalla, MD, MPH

Sadiya Sana Khan, BS

, and , report no financial interest/relationship relating to the topic of this activity.

  • Planners and Managers

The planners and managers reported no financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Steve Casebeer

(Impact Education, LLC)

Alicia Rybovic

(Pharmacy Times Office of Continuing Professional


Kay Weigand

(University of Cincinnati)

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. The University of Cincinnati, Pharmacy Times, Impact Education, LLC, and Otsuka America Pharmaceutical, Inc, do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati, Pharmacy Times, Impact Education, LLC, or Otsuka America Pharmaceutical, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Cincinnati and Impact Education, LLC. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The University of Cincinnati designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit

commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Accreditation Statement

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing

pharmacy education. This program is approved for 2.5 contact hours (0.25 CEUs) under the ACPE universal program number of 290-999-08-011-H01-P. This

program is available for CE credit through December 31, 2009.

Otsuka America Pharmaceutical, Inc.

This supplement was supported by

CH LogoCenter for Biosimilars Logo